This page contains brief information about pemetrexed disodium and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Pemetrexed disodium is approved to be used alone or with other drugs to treat:
- Malignant pleural mesothelioma in patients who cannot be treated with surgery.
- Non-small cell lung cancer (certain types) in patients whose disease is locally advanced or has metastasized (spread to other parts of the body).
Pemetrexed disodium is also being studied in the treatment of other types of cancer.
More About Pemetrexed Disodium
MedlinePlus Information on Pemetrexed Disodium – A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Clinical Trials Accepting Patients
Find Clinical Trials for Pemetrexed Disodium – Check for trials from TCH’s list of cancer clinical trials now accepting patients.
